The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for TP Maduskuie


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand.EBI
Dupont Pharmaceuticals
 
Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: ureas bearing heterocyclic groups bioisosteric for an imidazoleEBI
Dupont Pharmaceuticals
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.EBI
Bristol-Myers Squibb Pharmaceutical Research Institute
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: initial SAR studies.EBI
Dupont Pharmaceuticals
Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.EBI
Dupont Pharmaceuticals
Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.EBI
Dupont Pharmaceuticals
Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.EBI
Dupont Pharmaceuticals
Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.EBI
Ici Pharmaceuticals Group
Hetarylcoumarins: Synthesis and biological evaluation as potent a-glucosidase inhibitors.BDB
Kinnaird College For Women